IFP Advisors, Inc - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,133
-76.2%
1,975
-50.0%
0.00%
Q2 2023$8,967
+37.1%
3,950
+96.3%
0.00%
Q1 2023$6,539
+81637.5%
2,012
-0.4%
0.00%
Q4 2022$8
-99.9%
2,020
-0.3%
0.00%
Q3 2022$8,0000.0%2,0270.0%0.00%
Q2 2022$8,000
-50.0%
2,027
-50.4%
0.00%
Q1 2022$16,000
+166.7%
4,083
+98.6%
0.00%
Q4 2021$6,000
-33.3%
2,056
-0.3%
0.00%
Q3 2021$9,000
+12.5%
2,062
-4.4%
0.00%
Q2 2021$8,000
+33.3%
2,157
+16.8%
0.00%
Q1 2021$6,000
+50.0%
1,846
+53.6%
0.00%
Q4 2020$4,000
+100.0%
1,202
+9.8%
0.00%
Q3 2020$2,0000.0%1,0950.0%0.00%
Q2 2020$2,0000.0%1,0950.0%0.00%
Q1 2020$2,0001,0950.00%
Q4 2019$0
-100.0%
0
-100.0%
0.00%
Q3 2019$1,0000.0%5000.0%0.00%
Q4 2018$1,0005000.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 9,105,691$30,140,0005.99%
Sio Capital Management, LLC 1,888,181$6,250,0003.50%
DAFNA Capital Management LLC 473,478$1,567,0001.32%
Cormorant Asset Management, LP 2,000,000$6,620,0000.96%
Ghost Tree Capital, LLC 1,100,000$3,641,0000.68%
Rhenman & Partners Asset Management AB 1,282,000$4,243,0000.67%
Palo Alto Investors LP 4,254,623$14,083,0000.67%
NEA Management Company, LLC 3,243,150$10,375,0000.36%
Telemetry Investments, L.L.C. 170,000$563,0000.25%
NJ State Employees Deferred Compensation Plan 355,000$1,175,0000.22%
View complete list of RIGEL PHARMACEUTICALS INC shareholders